Pressure BioSciences, Inc.
PBIO
$0.0031
-$0.002-39.22%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 421.80K | 349.30K | 312.40K | 413.00K | 511.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 421.80K | 349.30K | 312.40K | 413.00K | 511.80K |
| Cost of Revenue | 377.50K | 233.30K | 333.50K | 229.50K | 256.60K |
| Gross Profit | 44.30K | 115.90K | -21.20K | 183.60K | 255.20K |
| SG&A Expenses | 1.68M | 1.33M | 3.11M | 1.19M | 1.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.35M | 1.83M | 3.80M | 1.71M | 1.59M |
| Operating Income | -1.93M | -1.48M | -3.49M | -1.29M | -1.08M |
| Income Before Tax | -7.12M | -8.07M | -9.90M | -5.63M | -6.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.12M | -8.07M | -9.90M | -5.63M | -6.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.12M | -8.07M | -9.90M | -5.63M | -6.92M |
| EBIT | -1.93M | -1.48M | -3.49M | -1.29M | -1.08M |
| EBITDA | -1.84M | -1.41M | -3.46M | -1.26M | -1.05M |
| EPS Basic | -0.15 | -0.22 | -0.33 | -0.29 | -0.57 |
| Normalized Basic EPS | -0.07 | -0.11 | -0.10 | -0.16 | -0.22 |
| EPS Diluted | -0.15 | -0.22 | -0.33 | -0.29 | -0.57 |
| Normalized Diluted EPS | -0.07 | -0.11 | -0.10 | -0.16 | -0.22 |
| Average Basic Shares Outstanding | 51.41M | 39.81M | 32.33M | 21.72M | 19.47M |
| Average Diluted Shares Outstanding | 51.41M | 39.81M | 32.33M | 21.72M | 19.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |